Market Pulse
Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
KnowBe4 received accreditation from Italy's Agenzia per la Cybersicurezza Nazionale (ACN) on September 3, 2026.
Read full analysis →
Mitrade EU introduced excess-of-loss insurance for eligible clients under its CySEC license, effective September 1, 2026.
Read full analysis →
ONWARD Medical has initiated the EIGER clinical feasibility study to evaluate the ARC-IM System for restoring mobility in individuals with subacute or chronic spinal cord injury (SCI).
Read full analysis →
Volvo Group, Daimler Truck, Toyota, and energy firms form a coalition to scale hydrogen truck deployment in Europe by 2030.
Read full analysis →
Sivers Semiconductors investing $30M to expand its Glasgow InP manufacturing facility, targeting 100M+ CW DFB lasers annually by Q4 2027.
Read full analysis →
Nokia partners with BeeHealthy to integrate Network as Code into digital healthcare platforms across Europe and the Middle East.
Read full analysis →
Sika AG completed the acquisition of Akkim, a Turkish adhesives and sealants manufacturer, on September 3, 2026.
Read full analysis →
Voltalia reported a 35% increase in half-year EBITDA to €110.3 million, driven by growth in Energy Sales and Renvolt.
Read full analysis →
Reborn Coffee (Nasdaq: REBN) received a Nasdaq notification on August 27, 2026, for failing to file its Q2 2026 10-Q report by the deadline.
Read full analysis →
Everest Medicines received NMPA approval for CARDAMYST® (etripamil) nasal spray for treating acute PSVT episodes in adults.
Read full analysis →
China’s NMPA approved LEQEMBI® (lecanemab) subcutaneous formulation for early Alzheimer’s disease initiation treatment.
Read full analysis →
HUTCHMED licenses HMPL-A830, a KRAS-EGFR antibody-targeted therapy conjugate, to GSK for $110M upfront and up to $1.295B in milestones.
Read full analysis →
Utopai Studios and DeNA's Entertainment Development Business Unit are collaborating to integrate Utopai's AI system PAI into DeNA's animation production workflows in Japan.
Read full analysis →
GeoPark acquires Bare Block in Venezuela’s Orinoco Heavy Oil Belt via a 25-year Production Participation Contract (CPP) with PPSA.
Read full analysis →
H2O.ai completed an IRAP assessment for H2O AI Cloud against the March 2026 version of Australia's ISM PROTECTED level controls.
Read full analysis →
XTransfer received in-principle approval for a Retail Payment Services Licence from the UAE Central Bank on September 2, 2026.
Read full analysis →
Diversified Energy PLC acquires Birch Permian Holdings for $1.8B, expanding its Permian Basin footprint.
Read full analysis →
Phase 1/2 trial data for RASONQUE (daraxonrasib) in metastatic non-small cell lung cancer (NSCLC) published in NEJM on September 2, 2026.
Read full analysis →
Walker & Dunlop arranged $390M in construction financing for Park Tower, a 47-story mixed-use development in Jersey City’s Journal Square.
Read full analysis →
Ivonescimab monotherapy demonstrated statistically significant overall survival (OS) benefit compared to pembrolizumab monotherapy in PD-L1-positive advanced NSCLC in the HARMONi-2 study.
Read full analysis →
